AUROBINDO PHARMA LTD

Pharmaceutical ManufacturingHyderabad, Telangana, India
Est. 1986Public Company14,814 Employees
Employees
~14,814
Founded
1986

About AUROBINDO PHARMA LTD

Key Facts
Approximately 14,814 employees globally
Headquartered in Hyderabad, Telangana, India
Operates in Pharmaceutical Manufacturing
Founded in 1986

Executive Leadership Team

Dilip Kastala
Dilip Kastala
Chief Information Officer, Aurobindo Biologics
Since 2024
Hemant Kumar Sharma
Since 2020
NR
Nityananda Reddy
Vice Chairman and Managing Director
Since 2022
RAVIKIRAN N
RAVIKIRAN N
Chief Business Officer
Since 2024
SS
Santhanam Subramanian
Group Chief Financial Officer
Since 2013

Organizational Chart — Preview

Powered by OrgKonnect
Live from OrgKonnect — bizkonnect.ai
See the Full Org Chart with Contact Details
Unlock reporting lines, direct contacts, connection paths, and business insights for all AUROBINDO PHARMA LTD's employees

AUROBINDO PHARMA LTD Executive Leadership Team

Dilip Kastala
Dilip Kastala
Chief Information Officer, Aurobindo Biologics
Leading digital transformation & process innovation agenda for Aurobindo Biologics as the Chief Information Officer. Passionate about powering scientific innovation & process excellence in pharma with digital & data science.
Since 2024
Hemant Kumar Sharma
Since 2020
NR
Nityananda Reddy
Vice Chairman and Managing Director
Since 2022
RAVIKIRAN N
RAVIKIRAN N
Chief Business Officer
As a Chief Business Officer at Aurobindo Pharma Ltd., I hold enterprise-wide P&L responsibility for the formulations business across emerging and regulated markets. The role involves direct engagement with the Chairman, driving growth, governance, and strategic expansion across multi-geography operations. My mandate spans business transformation, market entry, alliances, and full-spectrum leadership across commercial and enabling functions. ✅ Led enterprise P&L across India, APAC, South Asia, Africa, MENA, CIS, LATAM, and Europe, delivering high double-digit topline and bottom-line growth by reshaping portfolio and market strategies. ✅ Expanded global presence by executing new market entry, partnership, and alliance models across APAC, GCC, South Africa, LATAM, and Europe B2B and ARV segments. ✅ Directed large-scale business transformation initiatives, improving execution discipline, profitability, and decision velocity through operating model and structural changes. ✅ Oversaw cross-functional leadership across Sales, Marketing, Manufacturing, Regulatory, SCM, Finance, and Logistics, ensuring integrated execution across regions. ✅ Enabled inorganic growth readiness by supporting acquisition evaluation, post-merger integration planning, and governance oversight at board and subsidiary levels. ✅ Strengthened board and promoter confidence through regular engagement on capital allocation, growth roadmaps, and long-term enterprise vision. Global P&L Leadership, Business Transformation, Market Expansion Strategy, Board Engagement, Portfolio Governance
Since 2024
SS
Santhanam Subramanian
Group Chief Financial Officer
Aurobindo is a Indian Multination with a turnover around 3.0 Bn USD interested in Pharmaceuticals. Is a multi-divisional, multi-locational Company present in most of the segment in Pharma. Has a big presence in US and Europe operating in more than 50 countries..
Since 2013

Business Focus Areas

Identified by BizNLP
Business Focus Areas
GenericsFormulationR&DAPIvaccineBiologicsEnzymesInjectablesOncologyspecialty
🔓 to see the full technographic profile including all applications, infrastructure details, vendor contracts, and technology evaluation signals.

AUROBINDO PHARMA LTD Org Chart & Organizational Structure